Suchergebnisse - "Altenburg, Arwen F"

PubPharm (19)

1

Selective modulation of cell surface proteins during vaccinia infection : A resource for identifying viral immune evasion strategies

enthalten in: PLoS pathogens | 2022

von Depierreux, D. | Altenburg, A. | Soday, L. | +5

2

Selective modulation of cell surface proteins during vaccinia infection: implications for immune evasion strategies

enthalten in: bioRxiv.org | 2021

von Depierreux, D. | Altenburg, A. | Soday, L. | +5

3

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

enthalten in: The Journal of infectious diseases | 2018

von de Vries, R. | Altenburg, A. | Nieuwkoop, N. | +12

4

Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines

enthalten in: Scientific reports | 2018

von Altenburg, A. | van Trierum, S. | de Bruin, E. | +7

5

Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice

enthalten in: Immunologic research | 2018

von Magnusson, S. | Altenburg, A. | Bengtsson, K. | +4

6

Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice

enthalten in: Immunologic research | 2018

von Magnusson, S. | Altenburg, A. | Bengtsson, K. | +4

7

Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice

enthalten in: Immunologic research | 2018

von Magnusson, S. | Altenburg, A. | Bengtsson, K. | +4

8

Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice

enthalten in: Immunologic research | 2018

von Magnusson, S. | Altenburg, A. | Bengtsson, K. | +4

9

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

Erschienen: 2018

von de Vries, R. | Altenburg, A. | Nieuwkoop, N. | +12

10

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo

enthalten in: Scientific reports | 2017

von Altenburg, A. | van de Sandt, C. | Li, B. | +9